Clinical Trial Update: AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain [Phase 2]

View source ↗

Summary

Algiax Pharmaceuticals completed a Phase 2 trial evaluating AP-325 for peripheral post-surgical neuropathic pain. The update notes trial completion but does not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Peripheral Neuropathy

Drugs mentioned

• AP-325

Snippet

Sponsor: Algiax Pharmaceuticals GmbH | Conditions: Peripheral Post-surgical Neuropathic Pain | Phase 2 | Status: COMPLETED